Therapeutic Prospects of Ketamine for Cataplexy in Narcolepsy Type 1: Evidence from a Human Case and a Murine Model. [PDF]
Ricordeau F +8 more
europepmc +1 more source
Signal transduction, dimerization, and therapeutic targeting of Orexin and receptor systems. [PDF]
Zhang S +6 more
europepmc +1 more source
The therapeutic pipeline in migraine: What does the future hold? [PDF]
Gamal-Eltrabily M +3 more
europepmc +1 more source
Orexins, Psychosis, and Antipsychotics: A Systematic Review of Studies of Orexin Levels and the Effects of Dual Orexin Receptor Antagonists (DORAs). [PDF]
Margoni S +11 more
europepmc +1 more source
Temporal drift of sleep-wake representations in hypothalamic neuronal ensembles. [PDF]
Yan Y +4 more
europepmc +1 more source
The Role of Danavorexton for Perioperative Opioid-Induced Respiratory Depression and Sedation: A Narrative Review. [PDF]
Enache AJ +7 more
europepmc +1 more source
Awakening Recovery: Enhancing Orexinergic Tone After Acute CNS Damage. [PDF]
Otero-López P +3 more
europepmc +1 more source
Cerebrospinal fluid orexin testing in Australians with narcolepsy type 1. [PDF]
Fernando M +8 more
europepmc +1 more source
Orexin deficiency and cardiometabolic risk in narcolepsy: mechanistic pathways and therapeutic implications. [PDF]
Shukla A, Geer JH, Nokes B, Wojeck BS.
europepmc +1 more source

